Menicon posts higher FY2026 earnings and maintains dividend, eyes further sales growth

An update from Menicon Co ( (JP:7780) ) is now available.

Menicon reported consolidated net sales of ¥125.6 billion for the fiscal year ended March 31, 2026, up 3.4% year on year, with operating profit rising 2.2% to ¥10.2 billion and ordinary profit jumping 15.2% to ¥11.0 billion. Profit attributable to owners of parent grew 5.7% to ¥5.9 billion, while basic earnings per share reached ¥79.11, and improved comprehensive income and higher equity lifted the equity-to-asset ratio to 48.5%.

Total assets increased to ¥194.6 billion and cash and cash equivalents stood at ¥32.4 billion despite negative investing and financing cash flows, reflecting ongoing investment and balance sheet management. The company maintained an annual dividend of ¥28 per share and projects fiscal 2027 net sales of ¥133.0 billion and profit attributable to owners of parent of ¥6.5 billion, signaling expectations of continued top-line growth and earnings expansion amid a slight anticipated decline in ordinary profit.

The most recent analyst rating on (JP:7780) stock is a Buy with a Yen1900.00 price target. To see the full list of analyst forecasts on Menicon Co stock, see the JP:7780 Stock Forecast page.

More about Menicon Co

Menicon Co., Ltd., listed on the Tokyo and Nagoya stock exchanges under code 7780, operates in the eye care and contact lens industry. The company develops, manufactures, and sells contact lenses and related products, with a global market focus supported by overseas subsidiaries and a strategy centered on steady earnings growth and shareholder returns.

Average Trading Volume: 263,853

Technical Sentiment Signal: Hold

Current Market Cap: Yen122.4B

See more insights into 7780 stock on TipRanks’ Stock Analysis page.